Concepedia

Publication | Closed Access

Extent of radiosensitization by the PARP inhibitor olaparib depends on its dose, the radiation dose and the integrity of the homologous recombination pathway of tumor cells

DOI

111

Citations

29

References

2015

Year

Caroline V.M. Verhagen, Rosemarie de Haan, Floor Hageman, Tim P.D. Oostendorp, Annalisa L. E. Carli, Mark J. O’Connor, Jos Jonkers, Marcel Verheij, Michiel W. M. van den Brekel, Conchita Vens
Radiotherapy and Oncology

References

YearCitations

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

Hannah Farmer, Nuala McCabe, Christopher J. Lord,

Nature

2005

6.5K

Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase

Helen E. Bryant, Niklas Schultz, Huw D. Thomas,

Nature

2005

5.1K

Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from <i>BRCA</i> Mutation Carriers

Peter C.C. Fong, David S. Boss, Timothy A. Yap,

New England Journal of Medicine

2009

3.6K

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial

M. William Audeh, James Carmichael, Richard T. Penson,

The Lancet

2010

2.3K

Olaparib Monotherapy in Patients With Advanced Cancer and a Germline <i>BRCA1/2</i> Mutation

Bella Kaufman, Ronnie Shapira‐Frommer, Rita K. Schmutzler,

Journal of Clinical Oncology

2014

1.7K

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial

Andrew Tutt, Mark E. Robson, Judy E. Garber,

The Lancet

2010

1.6K

Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer

Jos Jonkers, Ralph Meuwissen, Hanneke van der Gulden,

Nature Genetics

2001

1.1K

High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs

Sven Rottenberg, Janneke E. Jaspers, Ariena Kersbergen,

Proceedings of the National Academy of Sciences

2008

943

ADP-ribosylation in mammalian cell ghosts. Dependence of poly(ADP-ribose) synthesis on strand breakage in DNA.

Robert C. Benjamin, D. Michael Gill

Journal of Biological Chemistry

1980

380

Selective Inhibition of BRCA2-Deficient Mammary Tumor Cell Growth by AZD2281 and Cisplatin

Bastiaan Evers, Rinske Drost, Eva Schut,

Clinical Cancer Research

2008

331

Page 1